/

Amgen Inc.

AMGN US

AMGN USAmgen Inc.

United States Composite

273.00

USD

-0.69

(-0.25%)

12.49EPS Dil.

21.73P/E

146.16BMarket Cap

3.12%Div. Yield

Amgen Inc.

AMGN

(United States Composite)

Recent

price

273.00

P/E

ratio

21.73

div

yld

3.12%

ROIC.AI

Legends:

Stock price

0.63

Beta (1.0 Market)

% total return 04/24

Stock

S&P500

YTD

10.01

- -

4.63

- -

50.83

- -

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

TTM

FRC

14.02

14.41

15.68

17.22

22.28

24.80

26.43

28.58

30.74

31.26

35.93

38.61

43.39

45.58

48.93

52.69

52.72

3.79

4.53

4.82

4.07

5.61

6.75

6.80

9.15

10.32

2.71

12.70

12.96

12.40

10.34

12.18

12.56

4.97

5.71

5.42

5.03

6.67

7.43

10.47

11.98

12.72

14.38

15.97

14.10

16.88

14.70

16.33

13.76

- -

0.55

1.44

1.88

2.44

3.16

4.01

4.60

5.31

5.80

6.41

7.04

7.80

8.52

19.36

22.74

25.53

23.70

25.01

29.50

33.91

37.88

41.12

35.89

21.08

17.25

17.97

13.43

7.29

12.18

5.79

3.48

11.14

5.90

3.21

-8.13

-2.24

2.19

6.57

2.59

-15.31

-41.33

-37.81

-41.86

-52.34

-84.12

1,070

1,016

960

905

775

753

759

758

748

731

661

605

586

570

538

535

15,003

14,642

15,053

15,582

17,265

18,676

20,063

21,662

22,991

22,849

23,747

23,362

25,424

25,979

26,323

28,190

34.75

37.60

36.84

27.67

32.30

31.41

30.86

39.10

42.60

43.65

43.22

41.41

35.95

35.20

36.34

28.01

1,073

1,049

1,017

1,060

1,088

1,286

2,092

2,108

2,105

1,955

1,946

2,206

3,601

3,398

3,417

4,071

4,052

4,605

4,627

3,683

4,345

5,081

5,158

6,939

7,722

1,979

8,394

7,842

7,264

5,893

6,552

6,717

19.20

11.51

12.98

11.25

13.26

3.49

7.65

13.02

15.73

79.38

12.06

14.18

10.68

12.06

10.81

14.49

27.01

31.45

30.74

23.64

25.17

27.21

25.71

32.03

33.59

8.66

35.35

33.57

28.57

22.68

24.89

23.83

10,335

15,059

16,559

21,839

23,018

19,420

27,705

29,851

34,806

40,456

24,130

5,605

9,491

7,201

6,499

11,940

9,176

10,601

10,874

21,344

24,034

29,623

30,215

29,182

30,193

34,190

29,510

26,950

32,895

33,222

37,354

63,170

20,386

22,667

23,944

19,029

19,060

22,096

25,778

28,083

29,875

25,241

12,500

9,673

9,409

6,700

3,661

6,232

14.13

15.27

13.67

9.84

11.24

11.35

10.33

12.70

13.31

3.29

16.87

19.18

19.58

19.16

20.19

11.61

15.13

16.07

14.64

10.91

12.27

12.16

11.09

13.55

14.06

3.56

17.74

20.50

20.10

16.50

18.67

16.10

21.28

21.47

19.94

17.27

23.01

24.68

21.47

25.53

26.22

7.03

42.84

66.83

70.54

65.88

115.07

129.01

Capital Structure

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

ST Debt

2,167

1,428

1,443

LT Borrowings

59,377

59,040

63,170

LT Finance Leases

- -

Preferred Equity and Hybrid Capital

- -

Shares Outstanding

535

Market Capitalization

118,758

143,813

154,206

Working Capital

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

Total Current Assets

47,380

48,477

30,332

Cash, Cash Equivalents & STI

34,248

34,741

10,944

Accounts Receivable, Net

5,830

6,145

7,268

Inventories

4,978

5,026

9,518

Total Current Liabilities

17,097

16,954

18,392

Payables & Accruals

14,930

15,526

15,568

ST Debt

2,167

1,428

1,443

Deferred Revenue

- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

4.26%

3.56%

7.09%

Net Income, GAAP

27.80%

-3.82%

2.52%

Free Cash Flow

4.20%

-5.99%

-16.23%

Total Cash Common Dividend

12.89%

5.42%

8.58%

Total Equity

-6.33%

-5.85%

70.23%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

2021

5,901

6,526

6,706

6,846

25,979

2022

6,238

6,594

6,652

6,839

26,323

2023

6,105

6,986

6,903

8,196

28,190

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

2021

2.85

0.81

3.32

3.37

10.34

2022

2.69

2.46

4.01

3.02

12.18

2023

5.32

2.58

3.23

1.43

12.56

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

2021

1.76

7.04

2022

1.97

1.94

7.80

2023

2.13

8.52

Business: Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Company News

Zacks
22 days ago
Here's Why Amgen (AMGN) Stock is Outperforming the Industry
Yahoo
22 days ago
Here's Why Amgen (AMGN) Stock is Outperforming the Industry
Tipranks
22 days ago
Analysts’ Top Healthcare Picks: Amgen (AMGN), Intra-Cellular Therapies (ITCI)
Reuters
22 days ago
US takes next step in Medicare drug price negotiations with pharma companies
Zacks
23 days ago
Amgen (AMGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Yahoo
23 days ago
Amgen (AMGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Yahoo
24 days ago
Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again
Zacks
24 days ago
Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again
Zacks
24 days ago
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
Zacks
24 days ago
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Zacks
a month ago
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Yahoo
a month ago
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Biopharmadive
a month ago
Bristol Myers says KRAS drug succeeds in key trial
Yahoo
a month ago
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Zacks
a month ago
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Zacks
a month ago
Should You Invest in the iShares Biotechnology ETF (IBB)?
Yahoo
a month ago
3 Biotech Stocks to Buy on the Dip: March 2024
Zacks
a month ago
Precision BioSciences (DTIL) Reports Q4 Loss, Lags Revenue Estimates
Yahoo
a month ago
7 Dow Stocks to Buy on the Dip: March 2024
Zacks
a month ago
Wall Street Awaits Consumer Confidence Data

Company News

Zacks
22 days ago
Here's Why Amgen (AMGN) Stock is Outperforming the Industry
Yahoo
22 days ago
Here's Why Amgen (AMGN) Stock is Outperforming the Industry
Tipranks
22 days ago
Analysts’ Top Healthcare Picks: Amgen (AMGN), Intra-Cellular Therapies (ITCI)
Reuters
22 days ago
US takes next step in Medicare drug price negotiations with pharma companies
Zacks
23 days ago
Amgen (AMGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Yahoo
23 days ago
Amgen (AMGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Yahoo
24 days ago
Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again
Zacks
24 days ago
Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again
Zacks
24 days ago
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
Zacks
24 days ago
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Zacks
a month ago
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Yahoo
a month ago
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Biopharmadive
a month ago
Bristol Myers says KRAS drug succeeds in key trial
Yahoo
a month ago
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Zacks
a month ago
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Zacks
a month ago
Should You Invest in the iShares Biotechnology ETF (IBB)?
Yahoo
a month ago
3 Biotech Stocks to Buy on the Dip: March 2024
Zacks
a month ago
Precision BioSciences (DTIL) Reports Q4 Loss, Lags Revenue Estimates
Yahoo
a month ago
7 Dow Stocks to Buy on the Dip: March 2024
Zacks
a month ago
Wall Street Awaits Consumer Confidence Data

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

TTM

FRC

14.02

14.41

15.68

17.22

22.28

24.80

26.43

28.58

30.74

31.26

35.93

38.61

43.39

45.58

48.93

52.69

52.72

3.79

4.53

4.82

4.07

5.61

6.75

6.80

9.15

10.32

2.71

12.70

12.96

12.40

10.34

12.18

12.56

4.97

5.71

5.42

5.03

6.67

7.43

10.47

11.98

12.72

14.38

15.97

14.10

16.88

14.70

16.33

13.76

- -

0.55

1.44

1.88

2.44

3.16

4.01

4.60

5.31

5.80

6.41

7.04

7.80

8.52

19.36

22.74

25.53

23.70

25.01

29.50

33.91

37.88

41.12

35.89

21.08

17.25

17.97

13.43

7.29

12.18

5.79

3.48

11.14

5.90

3.21

-8.13

-2.24

2.19

6.57

2.59

-15.31

-41.33

-37.81

-41.86

-52.34

-84.12

1,070

1,016

960

905

775

753

759

758

748

731

661

605

586

570

538

535

15,003

14,642

15,053

15,582

17,265

18,676

20,063

21,662

22,991

22,849

23,747

23,362

25,424

25,979

26,323

28,190

34.75

37.60

36.84

27.67

32.30

31.41

30.86

39.10

42.60

43.65

43.22

41.41

35.95

35.20

36.34

28.01

1,073

1,049

1,017

1,060

1,088

1,286

2,092

2,108

2,105

1,955

1,946

2,206

3,601

3,398

3,417

4,071

4,052

4,605

4,627

3,683

4,345

5,081

5,158

6,939

7,722

1,979

8,394

7,842

7,264

5,893

6,552

6,717

19.20

11.51

12.98

11.25

13.26

3.49

7.65

13.02

15.73

79.38

12.06

14.18

10.68

12.06

10.81

14.49

27.01

31.45

30.74

23.64

25.17

27.21

25.71

32.03

33.59

8.66

35.35

33.57

28.57

22.68

24.89

23.83

10,335

15,059

16,559

21,839

23,018

19,420

27,705

29,851

34,806

40,456

24,130

5,605

9,491

7,201

6,499

11,940

9,176

10,601

10,874

21,344

24,034

29,623

30,215

29,182

30,193

34,190

29,510

26,950

32,895

33,222

37,354

63,170

20,386

22,667

23,944

19,029

19,060

22,096

25,778

28,083

29,875

25,241

12,500

9,673

9,409

6,700

3,661

6,232

14.13

15.27

13.67

9.84

11.24

11.35

10.33

12.70

13.31

3.29

16.87

19.18

19.58

19.16

20.19

11.61

15.13

16.07

14.64

10.91

12.27

12.16

11.09

13.55

14.06

3.56

17.74

20.50

20.10

16.50

18.67

16.10

21.28

21.47

19.94

17.27

23.01

24.68

21.47

25.53

26.22

7.03

42.84

66.83

70.54

65.88

115.07

129.01